SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016761
Filing Date
2017-08-09
Accepted
2017-08-09 07:46:13
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gthx-10q_20170630.htm 10-Q 1631906
2 EX-31.1 gthx-ex311_337.htm EX-31.1 15854
3 EX-31.2 gthx-ex312_338.htm EX-31.2 15545
4 EX-32.1 gthx-ex321_339.htm EX-32.1 7306
5 EX-32.2 gthx-ex322_340.htm EX-32.2 7295
  Complete submission text file 0001564590-17-016761.txt   5358724

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gthx-20170630.xml EX-101.INS 1202592
7 XBRL TAXONOMY EXTENSION SCHEMA gthx-20170630.xsd EX-101.SCH 35987
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20170630_cal.xml EX-101.CAL 26655
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20170630_def.xml EX-101.DEF 121916
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20170630_lab.xml EX-101.LAB 260529
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20170630_pre.xml EX-101.PRE 202420
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 171016474
SIC: 2834 Pharmaceutical Preparations